Coexpression of matrix metalloproteinase-7 (MMP7) and phosphorylated insulin growth factor receptor I (pIGF-IR) as predictors of resistance to anti-EGFR therapy in advanced colorectal cancer (ACRC)
Citation
Horndler, C., Gallego, R., Alonso, V., Alonso, V., Escudero, P., Jimeno, M., ... Maurel, J. (2009). Coexpression of matrix metalloproteinase-7 (MMP7) and phosphorylated insulin growth factor receptor I (pIGF-IR) as predictors of resistance to anti-EGFR therapy in advanced colorectal cancer (ACRC): A GEMCAD study. Journal of Clinical Oncology, 27(15_suppl ), 4063. DOI: 10.1200/jco.2009.27.15_suppl.4063